Melphalan-associated enteropathy in recipients of allogeneic hematopoietic stem cell transplantation: analysis of our own data and a literature review

dc.contributor.author	S.B. Mukhammadiev
dc.contributor.author	S.S. Asilov
dc.contributor.author	K.A. Olimjonov
dc.contributor.author	N.Kh. Kakharova
dc.contributor.author	G.Z. Makhamadalieva
dc.contributor.author	A.A. Kayumov
dc.contributor.author	M.Yu. Drokov
dc.date.accessioned	2026-01-15T20:48:56Z
dc.date.issued	2026-01-14
dc.description.abstract	The widespread use of high-dose melphalan in conditioning regimens for allogeneic hematopoietic stem cell transplantation (allo-HSCT) has led to an increased incidence of melphalan-associated enteropathy (MAE), a severe toxic intestinal injury. A key challenge in management is its differentiation from acute graft-versus-host disease (GVHD)
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/emrp/article/view/7256
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/111178
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/emrp/article/view/7256/5987
dc.rights	https://creativecommons.org/licenses/by-nc/4.0
dc.source	Eurasian Medical Research Periodical; Vol. 52 (2026): EMRP; 1-5
dc.source	2795-7624
dc.subject	melphalan-associated enteropathy
dc.subject	allogeneic HSCT
dc.subject	graft-versus
dc.subject	intestinal toxicity
dc.title	Melphalan-associated enteropathy in recipients of allogeneic hematopoietic stem cell transplantation: analysis of our own data and a literature review
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: mukhammadiev_2026_melphalan-associated_enteropathy_in_reci.pdf
item.page.filesection.size: 324.9 KB
item.page.filesection.format: Adobe Portable Document Format